InvestorsHub Logo
Followers 10
Posts 1672
Boards Moderated 1
Alias Born 12/12/2004

Re: None

Sunday, 01/13/2013 4:11:55 AM

Sunday, January 13, 2013 4:11:55 AM

Post# of 5644
"The company is eligible to receive up to approximately $470 million in milestone payments and tiered royalties up to a mid-teens percentage rate." in regards to Gevokizumab ant there are others in pipe


[chart][/chart]

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XOMA News